Expression of integrins and Toll-like receptors in cervical cancer: Effect of infectious agents

Innate Immunity

Volumn 18, Issue 1, 2012, Pages 55-69

  Werner, Jeff ^a   Decarlo, Correne A ^b,d   Escott, Nicholas ^c   Zehbe, Ingeborg ^b   Ulanova, Marina ^a  

^a LAKEHEAD UNIVERSITY   (Canada)

^b Thunder Bay Regional Research Institute   (Canada)

^c THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Cervical cancer; integrins; Toll like receptors

Indexed keywords

BETA3 INTEGRIN; BETA4 INTEGRIN; BETA6 INTEGRIN; CD51 ANTIGEN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ARTICLE; BACTERIAL INFECTION; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; ESCHERICHIA COLI; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LACTOBACILLUS REUTERI; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BACTERIAL INFECTIONS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CERVIX UTERI; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA CHAINS; PAPILLOMAVIRUS INFECTIONS; TOLL-LIKE RECEPTOR 4; UTERINE CERVICAL NEOPLASMS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HUMAN PAPILLOMAVIRUS; LACTOBACILLUS REUTERI; PSEUDOMONAS AERUGINOSA;

EID: 84856013549     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425910392934     Document Type: Article

References (45)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 ; 189: 12-19 (Pubitemid 29406813)
2. zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology. 2009 ; 384: 260-265
3. Platz-Christensen JJ, Sundström E, Larsson PG. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand. 1994 ; 73: 586-588 (Pubitemid 24275525)
4. Smith JS, Bosetti C, Muñoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004 ; 111: 431-439 (Pubitemid 38998826)
5. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology. 2004 ; 127: S56-61
6. Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006 ; 208: 233-248 (Pubitemid 43126116)
7. Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene. 2008 ; 27: 218-224
8. Arnaout MA, Mahalingam B, Xiong JP. Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol. 2005 ; 21: 381-410 (Pubitemid 41740640)
9. Moschos SJ, Drogowski LM, Reppert SL, Kirkwood JM. Integrins and cancer. Oncology. 2007 ; 21: 13-20
10. Janes SM, Watt FM. New roles for integrins in squamous-cell carcinoma. Nat Rev Cancer. 2006 ; 6: 175-183 (Pubitemid 43292561)
11. Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta. 2007 ; 1775: 163-180 (Pubitemid 44881199)
12. Gruber G, Hess J, Stiefel C, et al. Correlation between the tumoral expression of β3-integrin and outcome in cervical cancer patients who had undergone radiotherapy. Br J Cancer. 2005 ; 92: 41-46 (Pubitemid 40188434)
13. Hazelbag S, Kenter GG, Gorter A, et al. Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol. 2007 ; 212: 316-324 (Pubitemid 47010065)
14. Hodivala KJ, Pei XF, Liu QY, et al. Integrin expression and function in HPV 16-immortalised human keratinocytes in the presence or absence of v-Ha-ras. Comparison with cervical intraepithelial neoplasia. Oncogene. 1994 ; 9: 943-948 (Pubitemid 24065935)
15. Pandey S, Mittal RD, Srivastava M, et al. Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299GLy, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol. 2009 ; 114: 501-505
16. Kim WY, Lee JW, Choi JJ, et al. Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer. 2008 ; 18: 300-305 (Pubitemid 351365208)
17. Yu L, Wang L, Li M, Zhong J, Wang Z, Chen S. Expression of Toll-like receptor 4 is down-regulated during progression of cervical neoplasia. Cancer Immunol Immunother. 2010 ; 59: 1011-1019
18. Pasloske BL, Finlay BB, Paranchych W. Cloning and sequencing of the Pseudomonas aeruginosa PAK pilin gene. FEBS Lett. 1985 ; 183: 408-412 (Pubitemid 15042761)
19. DeCarlo CA, Escott NG, Werner J, et al. Gene expression analysis of interferon kappa in laser capture microdissected cervical epithelium. Anal Biochem. 2008 ; 381: 59-66
20. Longuet M, Beaudenon S, Orth G. Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39. J Clin Microbiol. 1996 ; 34: 738-744 (Pubitemid 26065811)
21. Reuter S, Bartelmann M, Vogt M, et al. APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J. 1998 ; 17: 215-222 (Pubitemid 28041062)
22. Lin C, Chen H, Lin R, et al. Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods. 2007 ; 140: 1-9 (Pubitemid 46185588)
23. Andersen J, Al-Khairy D, Ingalls R. Innate immunity at the mucosal surface: role of Toll-like receptor 3 and Toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod. 2006 ; 74: 824-831
24. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008 ; 454: 436-444
25. van Waes C, Surh DM, Chen Z, et al. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res. 1995 ; 55: 5434-5444
26. Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol. 1997 ; 71: 2449-2456 (Pubitemid 27078628)
27. Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol. 2006 ; 80: 8940-8950 (Pubitemid 44359968)
28. Bates RC, Bellovin DI, Brown C. Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. 2005 ; 115: 339-347 (Pubitemid 40385475)
29. Ramos DM, Dang D, Sadler S. The role of the integrin ávĝ6 in regulating the epithelial to mesenchymal transition in oral cancer. Anticancer Res. 2009 ; 29: 125-130
30. Sheppard D. Integrin-mediated activation of latent transforming growth factor β. Cancer Metastasis Rev. 2005 ; 24: 395-402 (Pubitemid 41569979)
31. Massagué J. TGF beta in cancer. Cell. 2008 ; 134: 215-230
32. Mitra A, Chakrabarti J, Banerji A, Das S, Chatterjee A. Cultre of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2. J Cancer Res Clin Oncol. 2006 ; 132: 505-513 (Pubitemid 43938334)
33. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004 ; 5: 816-826 (Pubitemid 39336275)
34. Ulanova M, Gravelle S, Barnes R. The role of epithelial integrin receptors in recognition of pulmonary pathogens. J Innate Immun. 2008 ; 1: 4-17
35. Wang J, Manning B, Wu Q, Blankson S, Bouchier-Hays D, Redmond H. Endotoxin/Lipopolysaccharide activates NF-κB and enhances tumor cell adhesion and invasion through a β1 integrin-dependent mechanism. J Immunol. 2003 ; 170: 795-804 (Pubitemid 36070531)
36. Gravelle S, Barnes R, Hawdon N, et al. Up-regulation of integrin expression in lung adenocarcinoma cells caused by bacterial infection. Innate Immun. 2010 ; 16: 14-26
37. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like receptor 4-mediated signaling. J Immunol. 2002 ; 168: 2424-2432 (Pubitemid 34171846)
38. Herbst-Kralovetz MM, Quayle AJ, Ficarra M, et al. Quantification and comparison of Toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol. 2008 ; 59: 212-224 (Pubitemid 351250421)
39. Wang B, Li S, Southern PJ, Cleary PP. Streptococcal modulation of cellular invasion via TGF-beta1 signaling. Proc Natl Acad Sci USA. 2006 ; 104: 2380-2385 (Pubitemid 43271678)
40. Beisswenger C, Lysenko ES, Weiser JN. Early bacterial colonization induces Toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect Immun. 2009 ; 77: 2212-2220
41. Chang JH, Park JY, Kim SK. Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells. Immunology. 2006 ; 118: 164-170
42. Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 2005 ; 65: 5009-5014 (Pubitemid 40827306)
43. Kurpakus MA, Quaranta V, Jones JC. Surface relocation of alpha 6 beta 4 integrins and assembly of hemidesmosomes in an in vitro model of wound healing. J Cell Biol. 1991 ; 115: 1737-1750 (Pubitemid 21910013)
44. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993 ; 73: 309-319 (Pubitemid 23123309)
45. Breuss JM, Gallo J, DeLisser HM, et al. Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1995 ; 108: 2241-2251